Abstract
Objectives
To clarify the controversy between systemic lupus erythematosus (SLE) and thyroid disease, our study was designed to determine whether or not thyroid problems are associated with SLE.
Methods
We obtained the IEU GWAS database for summary information on genome-wide association studies (GWAS) of SLE and thyroid disease (hypothyroidism and hyperthyroidism) in people with European ancestry. Three approaches were employed to assess the causal link between SLE and thyroid disease: MR-Egger, weighted median (WM), and inverse variance weighted (IVW). The pleiotropy and heterogeneity were examined using a variety of techniques, including the MR-Egger intercept, the MR-PRESSO approach, and the Cochran’s Q test.
Results
MR analysis revealed a relationship between SLE and an elevated incidence of hypothyroidism (IVW OR: 1.004, 95% CI: [1.003, 1.005], P = 8.45E-16) and hyperthyroidism (IVW OR: 1.0009, 95% CI: [1.0005, 1.0010], P = 1.30E-5). Neither horizontal pleiotropy nor heterogeneity was detected in the sensitivity analysis.
Conclusion
Our MR study presents strong evidence demonstrating a link between SLE and an elevated risk of thyroid illness. This could help us learn more about what causes SLE and give people with SLE more thorough thyroid function tests and evaluations.
Key points • We did not discover modest heterogeneity and pleiotropy in our study. •The findings of this study indicate that SLE is related to an elevated risk of hypothyroidism and hyperthyroidism. |
Similar content being viewed by others
Data availability
The GWAS summary datasets for SLE (GWAS ID: ebi-a-GCST003156), hypothyroidism (GWAS ID: ukb-b-19732), and hyperthyroidism (GWAS ID: ukb-b-20289) are available through the ieu open gwas project (https://gwas.mrcieu.ac.uk/datasets).
Abbreviations
- SLE :
-
Systemic lupus erythematosus
- AITD :
-
Autoimmune thyroid diseases
- GW AS :
-
Genome-wide association study
- SNP :
-
Single nucleotide polymorphism
- MR :
-
Mendelian randomization
- WM :
-
Weighted median
- MR-Egger :
-
The Mendelian randomization-Egger
- IVW :
-
Inverse variance weighted
References
Barber MRW, Drenkard C, Falasinnu T et al (2021) Global epidemiology of systemic lupus erythematosus [published correction appears in Nat Rev Rheumatol 2021 Sep 1;]. Nat Rev Rheumatol 17(9):515–532. https://doi.org/10.1038/s41584-021-00668-1
Durcan L, O’Dwyer T, Petri M (2019) Management strategies and future directions for systemic lupus erythematosus in adults. Lancet 393(10188):2332–2343. https://doi.org/10.1016/S0140-6736(19)30237-5
Rahman A, Isenberg DA (2008) Systemic lupus erythematosus. N Engl J Med 358(9):929–939. https://doi.org/10.1056/NEJMra071297
Antonelli A, Ferrari SM, Corrado A, Di Domenicantonio A, Fallahi P (2015) Autoimmune thyroid disorders. Autoimmun Rev 14(2):174–180. https://doi.org/10.1016/j.autrev.2014.10.016
Goh KL, Wang F (1986) Thyroid disorders in systemic lupus erythematosus. Ann Rheum Dis 45(7):579–583. https://doi.org/10.1136/ard.45.7.579
Watad A, Mahroum N, Whitby A et al (2016) Hypothyroidism among SLE patients: case-control study. Autoimmun Rev 15(5):484–486. https://doi.org/10.1016/j.autrev.2016.01.019
Miller FW, Moore GF, Weintraub BD, Steinberg AD (1987) Prevalence of thyroid disease and abnormal thyroid function test results in patients with systemic lupus erythematosus. Arthritis Rheum 30(10):1124–1131. https://doi.org/10.1002/art.1780301006
Vianna JL, Haga HJ, Asherson RA, Swana G, Hughes GR (1991) A prospective evaluation of antithyroid antibody prevalence in 100 patients with systemic lupus erythematosus. J Rheumatol 18(8):1193–1195
Chan AT, Al-Saffar Z, Bucknall RC (2001) Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford) 40(3):353–354. https://doi.org/10.1093/rheumatology/40.3.353
Pyne D, Isenberg DA (2002) Autoimmune thyroid disease in systemic lupus erythematosus. Ann Rheum Dis 61(1):70–72. https://doi.org/10.1136/ard.61.1.70
Gao H, Li C, Mu R et al (2011) Subclinical hypothyroidism and its association with lupus nephritis: a case control study in a large cohort of Chinese systemic lupus erythematosus patients. Lupus 20(10):1035–1041. https://doi.org/10.1177/0961203311401456
Tsai RT, Chang TC, Wang CR, Chuang CY, Chen CY (1993) Thyroid disorders in Chinese patients with systemic lupus erythematosus. Rheumatol Int 13(1):9–13. https://doi.org/10.1007/BF00290328
Weetman AP, Walport MJ (1987) The association of autoimmune thyroiditis with systemic lupus erythematosus. Br J Rheumatol 26(5):359–361. https://doi.org/10.1093/rheumatology/26.5.359
Ronchezel MV, Len CA, Spinola e Castro A et al (2001) Thyroid function and serum prolactin levels in patients with juvenile systemic lupus erythematosus. J Pediatr Endocrinol Metab 14(2):165–169. https://doi.org/10.1515/jpem.2001.14.2.165
Lin WY, Chang CL, Fu LS, Lin CH, Lin HK (2015) Systemic lupus erythematosus and thyroid disease: A 10-year study. J Microbiol Immunol Infect 48(6):676–683. https://doi.org/10.1016/j.jmii.2014.03.004
Luo W, Mao P, Zhang L, Yang Z (2018) Association between systemic lupus erythematosus and thyroid dysfunction: a meta-analysis. Lupus 27(13):2120–2128. https://doi.org/10.1177/0961203318805849
Mader R, Mishail S, Adawi M, Lavi I, Luboshitzky R (2007) Thyroid dysfunction in patients with systemic lupus erythematosus (SLE): relation to disease activity. Clin Rheumatol 26(11):1891–1894. https://doi.org/10.1007/s10067-007-0602-5
Antonelli A, Ferri C, Ferrari SM, Colaci M, Fallahi P (2008) Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia. Autoimmun Rev 8(1):18–23. https://doi.org/10.1016/j.autrev.2008.07.017
Lee EY, Lee ZH, Song YW (2009) CXCL10 and autoimmune diseases. Autoimmun Rev 8(5):379–383. https://doi.org/10.1016/j.autrev.2008.12.002
Domingues SL, Gonçalves FT, Jorge MLMP, Limongi JE, Ranza R, Jorge PT (2017) High prevalence of hypothyroidism in systemic lupus erythematosus patients without an increase in circulating anti-thyroid antibodies. Endocr Pract 23(11):1304–1310. https://doi.org/10.4158/EP161664.OR
Sekula P, Del Greco MF, Pattaro C, Köttgen A (2016) Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephrol 27(11):3253–3265. https://doi.org/10.1681/ASN.2016010098
Davey Smith G, Hemani G (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23(R1):R89–R98. https://doi.org/10.1093/hmg/ddu328
Burgess S, Scott RA, Timpson NJ, Davey Smith G, Thompson SG, EPIC- InterAct consortium (2015) Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. Eur J Epidemiol. 30(7):543–552. https://doi.org/10.1007/s10654-015-0011-z
Skrivankova VW, Richmond RC, Woolf BAR et al (2021) Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement. JAMA 326(16):1614–1621. https://doi.org/10.1001/jama.2021.18236
Bentham J, Morris DL, Graham DSC et al (2015) Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus. Nat Genet 47(12):1457–1464. https://doi.org/10.1038/ng.3434
Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases [published correction appears in Nat Genet 2018 Aug; 50(8):1196]. Nat Genet 50(5):693–698. https://doi.org/10.1038/s41588-018-0099-7
Burgess S, Thompson SG, CRP CHD Genetics Collaboration (2011) (2011) Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol 40(3):755–764. https://doi.org/10.1093/ije/dyr036
Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–525. https://doi.org/10.1093/ije/dyv080
Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314. https://doi.org/10.1002/gepi.21965
Lawlor DA, Harbord RM, Sterne JA, Timpson N, Davey SG (2008) Mendelian randomization: using genes as instruments for making causal inferences in epidemiology. Stat Med 27(8):1133–1163. https://doi.org/10.1002/sim.3034
Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384(9957):1878–1888. https://doi.org/10.1016/S0140-6736(14)60128-8
White RG, Bass BH, Williams E (1961) Lymphadenoid goitre and the syndrome of systemic lupus erythematosus. Lancet 1(7173):368–373. https://doi.org/10.1016/s0140-6736(61)91537-9
Pan XF, Gu JQ, Shan ZY (2015) Patients with systemic lupus erythematosus have higher prevalence of thyroid autoantibodies: a systematic review and meta-analysis. PLoS One 10(4):0123291. https://doi.org/10.1371/journal.pone.0123291. (2015 Apr 23)
Liu YC, Lin WY, Tsai MC, Fu LS (2019) Systemic lupus erythematosus and thyroid disease - experience in a single medical center in Taiwan. J Microbiol Immunol Infect 52(3):480–486. https://doi.org/10.1016/j.jmii.2016.11.008
Liu X, Yuan J, Zhou H et al (2023) Association between systemic lupus erythematosus and primary hypothyroidism: evidence from complementary genetic methods. J Clin Endocrinol Metab 108(4):941–949. https://doi.org/10.1210/clinem/dgac614
Wu H, Cantor RM, Graham DS et al (2005) Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease. Arthritis Rheum 52(8):2396–2402. https://doi.org/10.1002/art.21223
Fallahi P, Ferrari SM, Ruffilli I et al (2016) The association of other autoimmune diseases in patients with autoimmune thyroiditis: review of the literature and report of a large series of patients. Autoimmun Rev 15(12):1125–1128. https://doi.org/10.1016/j.autrev.2016.09.009
Antonelli A, Fallahi P, Mosca M et al (2010) Prevalence of thyroid dysfunctions in systemic lupus erythematosus. Metabolism 59(6):896–900. https://doi.org/10.1016/j.metabol.2009.10.010
Robazzi TC, Adan LF (2012) Autoimmune thyroid disease in patients with rheumatic diseases. Rev Bras Reumatol 52(3):417–430
Huang T, Liu S, Huang J et al (2022) Prediction and associated factors of hypothyroidism in systemic lupus erythematosus: a cross-sectional study based on multiple machine learning algorithms. Curr Med Res Opin 38(2):229–235. https://doi.org/10.1080/03007995.2021.2015156
Antonelli A, Rotondi M, Fallahi P et al (2006) Increase of CXC chemokine CXCL10 and CC chemokine CCL2 serum levels in normal ageing. Cytokine 34(1–2):32–38. https://doi.org/10.1016/j.cyto.2006.03.012
Mohan C, Adams S, Stanik V, Datta SK (1993) Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med 177(5):1367–1381. https://doi.org/10.1084/jem.177.5.1367
Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12(2):121–127. https://doi.org/10.1016/s1074-7613(00)80165-x
Wilber JF, Utiger RD (1969) The effect of glucocorticoids on thyrotropin secretion. J Clin Invest 48(11):2096–2103. https://doi.org/10.1172/JCI106176
Nicoloff JT, Fisher DA, Appleman MD Jr (1970) The role of glucocorticoids in the regulation of thyroid function in man. J Clin Invest 49(10):1922–1929. https://doi.org/10.1172/JCI106411
Acknowledgements
For the data used in these analyses, we gratefully acknowledge the ieu open gwas project (https://gwas.mrcieu.ac.uk/datasets/) and the Phenoscanner database (http://www.phenoscanner.medschl.cam.ac.uk/).
Author information
Authors and Affiliations
Contributions
LD: writing—original draft preparation, conceptualization, data curation; YS: methodology, visualization; YF: mentoring, editing, and writing—review. All authors made contributions to the article and approved the final manuscript version.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The data used in our MR analysis is entirely from previously reported summary data. Therefore, neither patient consent nor ethical approval was necessary for the study.
Disclosures
None.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Duan, L., Shi, Y. & Feng, Y. Systemic lupus erythematosus and thyroid disease: a Mendelian randomization study. Clin Rheumatol 42, 2029–2035 (2023). https://doi.org/10.1007/s10067-023-06598-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-023-06598-5